NEPHROTIC SYNDROME IN MINIMAL CHANGE DISEASE
- Authors: Tsygln A.1
-
Affiliations:
- Research Center for Children’s Health, Russian Academy of Medical Sciences
- Issue: Vol 24, No 6 (2013)
- Pages: 2-6
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115635
- ID: 115635
Cite item
Open Access
Access granted
Abstract
Minimal change disease is a morphological basis for the most common type of childhood nephrotic syndrome sensitive to corticosteroid therapy. The paper considers the immunopathogenesis of the disease, as well as steroid, symptomatic, and immunosuppressive therapies.
Keywords
Full Text
About the authors
A. Tsygln
Research Center for Children’s Health, Russian Academy of Medical Sciences
Email: a_tsygin@mail.ru
Professor
References
- Смирнов А.В., Шилов Е.М., Добронравов В.А. и др. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению // Нефрология. - 2012; 16 (1): 89-115.
- Цыгин А.Н., Сторожевых Т.П., Гозалишвили Т.В. и др. Пульс-терапия метилпреднизолоном в комплексном лечении гломерулонефрита у детей // Педиатрия. - 1995; 5: 27-9.
- Bagga A., Mantan M. Nephrotic syndrome in children // Ind. J. Med. Res. -2005; 122: 13-28.
- Bargman J. Management of minimal lesion glomerulonephritis: evidence-based recommendations // Kidney Int. - 1999; 70 (suppl): 3-16.
- Eddy A., Simmons J.M. Nephrotic syndrome in childhood // Lancet. - 2003; 362: 629-39.
- Clark A., Barratt T. Steroid-responsive nephrotic syndrome. In: Barratt T.M., Avner E.D., Harmon W.E. (eds). Pediatric nephrology. Lippinkott Williams & Wilkins, Baltimore. 1997: 731-47.
- Gulati A., Sinha A., Jordan S. et al. Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report // Clin. J. Am. Soc. Nephrol. - 2010; 5 (12): 2207-12.
- Hodson E., Willis N., Craig J. Corticosteroid therapy for Nephrotic syndrome in children // Cochrane Database Syst. Rev. - 2007; CD001533.
- Hogg R., Fitzgibbons L., Bruick J. et al. Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group // Clin. J. Am. Soc. Nephrol. - 2006; 1 (6): 1173-8.
- Hulton S., Neuhaus T., Dillon M. et al. Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood // Ped. Nephrol. - 1994; 8: 401-3.
- Latta K., von Schnakenburg C., Ehrich J. A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children // Ped. Nephrol. - 2001; 16: 271-82.
- Matieson P. Immune dysregulation in minimal change nephropathy // Nephrol., Dialys., Transplant. - 2003; 18 (6): 26-9.
- Mundel P., Shancland S.J. Podocyte biology and response to injury // J. Am. Soc. Nephrol. - 2003; 13: 3005-15.
- Niaudet P., Broyer M., Habib R. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children // Clin. Nephrol. - 1991; 35: 31-6.
- Oh J., Kemper M.J. Minimal change (steroid sensitive) nephrotic syndrome in children: new aspects on pathogenesis and treatment // Min. Pediatr. - 2012; 64 (2): 197-204.
- Ruth E., Kemper M., Leumann E. et al. Children with steroid-sensitive nephrotic syndrome come of age: Long-term outcome // J. Pediatr. - 2005; 147: 202-7.
- Singhal R., Brimble K. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management // Thromb. Res. - 2006; 118 (3): 397-407.
- Van Husen M., Kemper M. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome // Pediatr. Nephrol. - 2011; 26 (6): 88192.
- Vande Walle J., Donckerwolke R. Pathogenesis of edema formation in the nephrotic syndrome // Ped. Nephrol. - 2001; 16: 61-8.
- Waldman M., Crew R.J., Valeri A. et al. Adult Minimal-Change Disease: Clinical Characteristics, Treatment, and Outcomes // CJASN. - 2007; 2 (3): 445-53.
Supplementary files
